Chemomab Therapeutics Ltd.

NASDAQ: CMMB
Share price (1/8/25): $2.22
Market cap (1/8/25): $31.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 03/31/23 Q1

ended 12/31/22 FY 2022

ended 09/30/22 Q3

ended 06/30/22 Q2

Prospectuses and Registrations Filter

Updated info for already-effective prospectus

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Exempt offering of securities

Ownership Filter

OrbiMed Israel BioFund GP Limited Partnership

OrbiMed Israel GP Ltd.

Sphera Funds Management Ltd.

News Filter

Material disclosure

Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Dear Chemomab Therapeutics Ltd. Shareholders

Cautionary Note About Forward-Looking Statements

Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients With Primary Sclerosing Cholangitis

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness